NOVARTIS INDIA
Quarterly Results Analysis [Dec2024]
NOVARTIS INDIA Quarterly Results
Standalone | Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹93 Cr | ₹87 Cr | ₹92 Cr | ₹81 Cr | ₹85 Cr | ₹79 Cr | ₹91 Cr | ₹76 Cr |
Expenses | ₹67 Cr | ₹69 Cr | ₹68 Cr | ₹70 Cr | ₹65 Cr | ₹62 Cr | ₹73 Cr | ₹67 Cr |
Operating Income | ₹26 Cr | ₹18 Cr | ₹24 Cr | ₹11 Cr | ₹20 Cr | ₹17 Cr | ₹17 Cr | ₹9 Cr |
Other Income | ₹11 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹22 Cr | ₹17 Cr | ₹12 Cr | ₹16 Cr |
Interest | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr |
Depreciation | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹2 Cr | ₹2 Cr |
Profit Before Tax | ₹35 Cr | ₹28 Cr | ₹34 Cr | ₹21 Cr | ₹41 Cr | ₹32 Cr | ₹28 Cr | ₹23 Cr |
Profit After Tax | ₹25 Cr | ₹20 Cr | ₹26 Cr | ₹15 Cr | ₹27 Cr | ₹24 Cr | ₹20 Cr | ₹25 Cr |
EPS | ₹10.31 | ₹8.27 | ₹10.43 | ₹5.95 | ₹10.77 | ₹9.59 | ₹8.21 | ₹10.14 |
Industry Peers & Returns | 1W | 1M | 1Y |
NOVARTIS INDIA | 2.3% | 2% | -23% |
ADANI ENTERPRISES | 0.6% | 8.8% | -26.2% |
REDINGTON | -12% | -6.4% | 2.8% |
MMTC | -1.3% | 2.7% | -25.5% |
HONASA CONSUMER | 1.1% | 7.9% | -42% |
LLOYDS ENTERPRISES | 12.2% | 19.5% | 66.5% |
ENTERO HEALTHCARE SOLUTIONS | 3.7% | -7.4% | 18.5% |
OPTIEMUS INFRACOM | -2.5% | -3.4% | 61.5% |
POLO QUEEN INDUSTRIAL & FINTECH | 14.8% | -32.6% | 43.1% |
NOVARTIS INDIA Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 6.77 % |
Y-o-Y | 10.01 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2024 | ₹93 Cr | 6.77 | |
Sep2024 | ₹87 Cr | -5.62 | |
Jun2024 | ₹92 Cr | 13.70 | |
Mar2024 | ₹81 Cr | -3.99 | |
Dec2023 | ₹85 Cr | 7.34 | |
Sep2023 | ₹79 Cr | -13.07 | |
Jun2023 | ₹91 Cr | 19.01 | |
Mar2023 | ₹76 Cr | - |
NOVARTIS INDIA Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 42.43 % |
Y-o-Y | 29.39 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2024 | ₹26 Cr | 42.43 | |
Sep2024 | ₹18 Cr | -25.07 | |
Jun2024 | ₹24 Cr | 113.83 | |
Mar2024 | ₹11 Cr | -43.30 | |
Dec2023 | ₹20 Cr | 16.91 | |
Sep2023 | ₹17 Cr | -2.37 | |
Jun2023 | ₹17 Cr | 85.84 | |
Mar2023 | ₹9 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 33.41 % |
Y-o-Y | 17.61 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2024 | 27.51% | 33.41 | |
Sep2024 | 20.62% | -20.60 | |
Jun2024 | 25.97% | 88.05 | |
Mar2024 | 13.81% | -40.96 | |
Dec2023 | 23.39% | 8.94 | |
Sep2023 | 21.47% | 12.29 | |
Jun2023 | 19.12% | 56.21 | |
Mar2023 | 12.24% | - |
NOVARTIS INDIA Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 24.69 % |
Y-o-Y | -4.22 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2024 | ₹25 Cr | 24.69 | |
Sep2024 | ₹20 Cr | -20.71 | |
Jun2024 | ₹26 Cr | 75.34 | |
Mar2024 | ₹15 Cr | -44.75 | |
Dec2023 | ₹27 Cr | 12.20 | |
Sep2023 | ₹24 Cr | 16.88 | |
Jun2023 | ₹20 Cr | -19.02 | |
Mar2023 | ₹25 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 16.82 % |
Y-o-Y | -12.92 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2024 | 27.37 % | 16.82 | |
Sep2024 | 23.43 % | -15.99 | |
Jun2024 | 27.89 % | 54.17 | |
Mar2024 | 18.09 % | -42.44 | |
Dec2023 | 31.43 % | 4.52 | |
Sep2023 | 30.07 % | 34.48 | |
Jun2023 | 22.36 % | -31.95 | |
Mar2023 | 32.86 % | - |
NOVARTIS INDIA Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 24.67 % |
Y-o-Y | -4.27 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2024 | ₹10.31 | 24.67 | |
Sep2024 | ₹8.27 | -20.71 | |
Jun2024 | ₹10.43 | 75.29 | |
Mar2024 | ₹5.95 | -44.75 | |
Dec2023 | ₹10.77 | 12.30 | |
Sep2023 | ₹9.59 | 16.81 | |
Jun2023 | ₹8.21 | -19.03 | |
Mar2023 | ₹10.14 | - |
You may also like the below Video Courses
ADANI ENTERPRISES LTD vs REDINGTON LTD vs MMTC LTD
HONASA CONSUMER LTD vs LLOYDS ENTERPRISES LTD vs ENTERO HEALTHCARE SOLUTIONS LTD